Delaware
(State
or Other Jurisdiction of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
|
o
|
Written
communications pursuant to Rule 425 under the Securities
Act.
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Keryx
Biopharmaceuticals, Inc.
|
|||
(Registrant)
|
|||
Date:
December 2, 2009
|
|||
By:
|
/s/
James F. Oliviero
|
||
James
F. Oliviero
|
|||
Chief
Financial Officer
|
Exhibit
|
|
Number
|
Description
|
99.1
|
Press
Release dated December 2, 2009
|